Literature DB >> 23375202

Evaluating reported candidate gene associations with polycystic ovary syndrome.

Cindy Pau1, Richa Saxena, Corrine Kolka Welt.   

Abstract

OBJECTIVE: To replicate variants in candidate genes associated with polycystic ovary syndrome (PCOS) in a population of European women with PCOS and control subjects.
DESIGN: Case-control association analysis and meta-analysis.
SETTING: Major academic hospital. PATIENT(S): Women of European ancestry with PCOS (n = 525) and controls (n = 472), aged 18-45 years. INTERVENTION(S): Variants previously associated with PCOS in candidate gene studies were genotyped (n = 39). Metabolic, reproductive, and anthropomorphic parameters were examined as a function of the candidate variants. All genetic association analyses were adjusted for age, body mass index, and ancestry and were reported after correction for multiple testing. MAIN OUTCOME MEASURE(S): Association of candidate gene variants with PCOS. RESULT(S): Three variants, rs3797179 (SRD5A1), rs12473543 (POMC), and rs1501299 (ADIPOQ), were nominally associated with PCOS. However, they did not remain significant after correction for multiple testing, and none of the variants replicated in a sufficiently powered meta-analysis. Variants in the FBN3 gene (rs17202517 and rs73503752) were associated with smaller waist circumferences, and variant rs727428 in the SHBG gene was associated with lower sex hormone-binding globulin levels. CONCLUSION(S): Previously identified variants in candidate genes do not seem to be associated with PCOS risk. CLINICAL TRIAL REGISTRATION NUMBER: NCT00166569.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375202      PMCID: PMC3722586          DOI: 10.1016/j.fertnstert.2012.12.033

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  40 in total

1.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits.

Authors:  S Purcell; S S Cherny; P C Sham
Journal:  Bioinformatics       Date:  2003-01       Impact factor: 6.937

2.  A high-density admixture map for disease gene discovery in african americans.

Authors:  Michael W Smith; Nick Patterson; James A Lautenberger; Ann L Truelove; Gavin J McDonald; Alicja Waliszewska; Bailey D Kessing; Michael J Malasky; Charles Scafe; Ernest Le; Philip L De Jager; Andre A Mignault; Zeng Yi; Guy De The; Myron Essex; Jean-Louis Sankale; Jason H Moore; Kwabena Poku; John P Phair; James J Goedert; David Vlahov; Scott M Williams; Sarah A Tishkoff; Cheryl A Winkler; Francisco M De La Vega; Trevor Woodage; John J Sninsky; David A Hafler; David Altshuler; Dennis A Gilbert; Stephen J O'Brien; David Reich
Journal:  Am J Hum Genet       Date:  2004-04-14       Impact factor: 11.025

3.  Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.

Authors:  R Saxena; C K Welt
Journal:  Acta Diabetol       Date:  2012-03-03       Impact factor: 4.280

4.  A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

Authors:  M Asunción; R M Calvo; J L San Millán; J Sancho; S Avila; H F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

5.  Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Authors:  D A Ehrmann; R B Barnes; R L Rosenfield; M K Cavaghan; J Imperial
Journal:  Diabetes Care       Date:  1999-01       Impact factor: 19.112

Review 6.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity.

Authors:  José L San Millán; Marta Cortón; Gemma Villuendas; José Sancho; Belén Peral; Héctor F Escobar-Morreale
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  The prevalence and features of the polycystic ovary syndrome in an unselected population.

Authors:  Ricardo Azziz; Keslie S Woods; Rosario Reyna; Timothy J Key; Eric S Knochenhauer; Bulent O Yildiz
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

9.  Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

Authors:  R S Legro; A R Kunselman; W C Dodson; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

10.  Discerning the ancestry of European Americans in genetic association studies.

Authors:  Alkes L Price; Johannah Butler; Nick Patterson; Cristian Capelli; Vincenzo L Pascali; Francesca Scarnicci; Andres Ruiz-Linares; Leif Groop; Angelica A Saetta; Penelope Korkolopoulou; Uri Seligsohn; Alicja Waliszewska; Christine Schirmer; Kristin Ardlie; Alexis Ramos; James Nemesh; Lori Arbeitman; David B Goldstein; David Reich; Joel N Hirschhorn
Journal:  PLoS Genet       Date:  2007-11-19       Impact factor: 5.917

View more
  9 in total

Review 1.  Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood.

Authors:  David H Abbott; Fida Bacha
Journal:  Fertil Steril       Date:  2013-07       Impact factor: 7.329

Review 2.  Genetics of polycystic ovary syndrome.

Authors:  Corrine K Welt; Jessica M Duran
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 3.  Polycystic ovary syndrome: current status and future perspective.

Authors:  Erin K Barthelmess; Rajesh K Naz
Journal:  Front Biosci (Elite Ed)       Date:  2014-01-01

4.  Association between sex hormone binding globulin gene polymorphism and type 2 diabetes mellitus.

Authors:  Li Quan; Liang Wang; Jing Wang; Binya Yuwen; Jun Zhu
Journal:  Int J Clin Exp Pathol       Date:  2019-09-01

5.  Effects of ADIPOQ polymorphisms on PCOS risk: a meta-analysis.

Authors:  Zhengling Liu; Zengyan Wang; Changhong Hao; Yonghui Tian; Jingjing Fu
Journal:  Reprod Biol Endocrinol       Date:  2018-12-03       Impact factor: 5.211

6.  Hyperandrogenism in POMCa-deficient zebrafish enhances somatic growth without increasing adiposity.

Authors:  Chuang Shi; Yao Lu; Gang Zhai; Jianfei Huang; Guohui Shang; Qiyong Lou; Dongliang Li; Xia Jin; Jiangyan He; Zhenyu Du; Jianfang Gui; Zhan Yin
Journal:  J Mol Cell Biol       Date:  2020-05-18       Impact factor: 6.216

7.  Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes.

Authors:  Hyejin Lee; Yeon-Ah Sung; So-Hyeon Hong; Young Sun Hong; Kyungah Jeong; Hyewon Chung
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.379

8.  Whole Genome Sequencing instead of Whole Exome Sequencing is required to identify the Genetic Causes of Polycystic Ovary Syndrome in Pakistani families.

Authors:  Muhammad Jaseem Khan; Rubina Nazli; Jawad Ahmed; Sulman Basit
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

9.  A Comprehensive Overview of Common Polymorphic Variants in Genes Related to Polycystic Ovary Syndrome.

Authors:  Tatiana Castillo-Higuera; María Camila Alarcón-Granados; Johana Marin-Suarez; Harold Moreno-Ortiz; Clara Inés Esteban-Pérez; Atilio Junior Ferrebuz-Cardozo; Maribel Forero-Castro; Gloria Camargo-Vill Alba
Journal:  Reprod Sci       Date:  2020-11-10       Impact factor: 3.060

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.